06.17.24
DHL Supply Chain has expanded its specialized logistics services for the life sciences and healthcare sector in France through a long-term strategic partnership with Sanofi. DHL Supply Chain will provide warehousing, inventory management, picking and packing, and order fulfillment across three key sites in France: Amilly Distribution, Croissy-Beaubourg, and Saint-Loubès.
“This partnership strategically expands our existing, multi-country collaboration with Sanofi. By leveraging our combined global reach and scale and expertise in Healthcare in EMEA, we unlock significant synergies to optimize customer supply chains and create greater resilience,” said Hendrik Venter, regional CEO for DHL Supply Chain EMEA. “By actively scaling our life sciences and healthcare division, we will solidify our position as the leading provider of end-to-end solutions across the entire value chain. This not only increases value for our customers by supporting them in meeting changing patient needs, but ultimately improves patient outcomes.”
Ruth Beadle, head of global supply chain, Sanofi, said, “We are delighted to partner with DHL to continue delivering the highest quality products in a sustainable way from France. We strongly believe that the Amilly, Croissy Beaubourg and Saint-Loubès distribution centers with its employees will continue to exercise same strive for excellence with DHL, through a new journey that will bring the most value to our customers and patients in France and all around the world.”
Leveraging its resources, investments, and international network in the life sciences and healthcare sector, DHL Supply Chain aims to enhance the efficiency, resiliency and standards of Sanofi’s logistics network. This partnership is further reinforced by DHL’s experience across various segments, including pharmaceuticals, biopharmaceuticals, consumer health, vaccines, medical devices, clinical trials, hospitals, and healthcare establishments.
“Our dedicated team is highly trained and experienced in handling the specific requirements of life science products. We have the infrastructure, technology and know-how to ensure quality assurance and rigorous compliance with French regulation,” said Nico Schütz, CEO DHL Supply Chain France. “This strategic agreement serves as a lever to further develop our life sciences and healthcare division in France and the wider EMEA region.”
Beyond the immediate impact on the French market, the partnership with Sanofi holds strategic importance for DHL, aligning with its vision for growth in the EMEA region and leveraging its global footprint in the life sciences and healthcare sector.
“This partnership strategically expands our existing, multi-country collaboration with Sanofi. By leveraging our combined global reach and scale and expertise in Healthcare in EMEA, we unlock significant synergies to optimize customer supply chains and create greater resilience,” said Hendrik Venter, regional CEO for DHL Supply Chain EMEA. “By actively scaling our life sciences and healthcare division, we will solidify our position as the leading provider of end-to-end solutions across the entire value chain. This not only increases value for our customers by supporting them in meeting changing patient needs, but ultimately improves patient outcomes.”
Ruth Beadle, head of global supply chain, Sanofi, said, “We are delighted to partner with DHL to continue delivering the highest quality products in a sustainable way from France. We strongly believe that the Amilly, Croissy Beaubourg and Saint-Loubès distribution centers with its employees will continue to exercise same strive for excellence with DHL, through a new journey that will bring the most value to our customers and patients in France and all around the world.”
Leveraging its resources, investments, and international network in the life sciences and healthcare sector, DHL Supply Chain aims to enhance the efficiency, resiliency and standards of Sanofi’s logistics network. This partnership is further reinforced by DHL’s experience across various segments, including pharmaceuticals, biopharmaceuticals, consumer health, vaccines, medical devices, clinical trials, hospitals, and healthcare establishments.
“Our dedicated team is highly trained and experienced in handling the specific requirements of life science products. We have the infrastructure, technology and know-how to ensure quality assurance and rigorous compliance with French regulation,” said Nico Schütz, CEO DHL Supply Chain France. “This strategic agreement serves as a lever to further develop our life sciences and healthcare division in France and the wider EMEA region.”
Beyond the immediate impact on the French market, the partnership with Sanofi holds strategic importance for DHL, aligning with its vision for growth in the EMEA region and leveraging its global footprint in the life sciences and healthcare sector.
